Targeted Therapy for MPNs: Going Beyond JAK Inhibitors
Evan C. Chen(Dana-Farber Cancer Institute), Anand Patel(Ascension), Hannah Johnston(University of Illinois Chicago)
Cited by 2
Related Papers
VTE in ICU Patients With COVID-19
|CHEST Journal|2020|92
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
|OncoTargets and Therapy|2018|53